Skip to main content
editorial
. 2010 Feb;33(2):453–455. doi: 10.2337/dc09-1902

Figure 1.

Figure 1

Theoretical model to explain currently available observations with increased risks for pancreatic cancer in individuals with obesity and type 2 diabetes, a risk that is decreased by metformin treatment and theoretically may be increased by GLP-1–based treatment.